Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Immunome, Inc. IMNM

Set alert

Price alert · IMNM

All alert types
19.94 USD +0.35 +1.79%

As of Nov 3, 10:55 AM ET

Bid
19.88 × 2
Ask
19.98 × 1
19.78 Day range 20.19
14.64 52-week range 30.06
YTD
-7.17%
1 year
+17.29%
Open
19.81
Prev close
19.59
Mkt cap
2.35B
Vol
171.85K
Avg vol
1.30M
EPS
-2.52
P/E
0.00
Div yield
0.00%
More statistics
Low
19.78
High
20.19
Forward P/E
-7.97
Beta
2.66
Short ratio
10.98
Inst. own
103.76%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
22.44
200-d avg
22.49
1y target
35.33

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 11, 2026Earnings: -0.65; estimate -0.51381; surprise -26.51%
  • Aug 12, 2026Rating: Truist Securities · Buy → Buy
  • Sep 10, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 21, 2026Rating: Alliance Global Partners · — → Buy
  • Oct 1, 2026Rating: Stifel · — → Hold
  • Oct 16, 2026Rating: William Blair · — → Outperform
  • Oct 27, 2026Rating: Wedbush · Outperform → Outperform
Signals (13)
NameDateAgo
SMA: BullishNov 2, 20261 day ago
MACD: Buy SignalOct 22, 20261 week ago
RSI: OversoldOct 12, 20263 weeks ago
RSI: OversoldOct 6, 20264 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalAug 28, 20262 months ago
RSI: OverboughtAug 19, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago
RSI: OverboughtAug 5, 20263 months ago
MACD: Buy SignalAug 4, 20263 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 35.33 +77.2% upside
Target (low)
24.00
Target (mean)
35.33
Target (high)
40.00
Ratings (0m) 17 16 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy13
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 17
  • 1 month ago 16
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IMNM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.5976-0.71 – -0.41-0.65+8.1%133.33K0.0%15
Next quarter-0.6322-0.77 – -0.523-0.76+16.8%133.33K0.0%15
Current year-2.33-2.56 – -2.02-2.43+4.2%266.67K-96.2%14
Next year-2.46-3.13 – -1.85-2.33-5.6%50.41M+18804.0%13

Upgrades and downgrades

The latest rating changes

IMNM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 27, 2026WedbushReiteratedOutperformOutperform
Oct 16, 2026William BlairInitiated—Outperform
Oct 1, 2026StifelInitiated—Hold
Sep 21, 2026Alliance Global PartnersInitiated—Buy
Sep 10, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2026Truist SecuritiesMaintainedBuyBuy
Aug 12, 2026WedbushMaintainedOutperformOutperform
Jul 21, 2026WedbushReiteratedOutperformOutperform
Jun 12, 2026WedbushReiteratedOutperformOutperform
May 28, 2026Truist SecuritiesMaintainedBuyBuy
May 28, 2026BarclaysInitiated—Overweight
May 15, 2026Leerink PartnersMaintainedOutperformOutperform
May 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 4, 2026Craig-HallumMaintainedBuyBuy
Mar 4, 2026Stephens & Co.MaintainedOverweightOverweight
Feb 12, 2026HC Wainwright & Co.Initiated—Buy
Jan 15, 2026WedbushReiteratedOutperformOutperform
Dec 16, 2025Lake StreetMaintainedBuyBuy
Dec 16, 2025Evercore ISI GroupMaintainedOutperformOutperform
Dec 16, 2025GuggenheimMaintainedBuyBuy
Dec 1, 2025Truist SecuritiesInitiated—Buy
Nov 17, 2025Stephens & Co.MaintainedOverweightOverweight
Sep 22, 2025Goldman SachsInitiated—Buy
Sep 5, 2025Craig-HallumInitiated—Buy
Aug 25, 2025GuggenheimReiteratedBuyBuy
Aug 22, 2025Evercore ISI GroupInitiated—Outperform
Aug 7, 2025JP MorganMaintainedOverweightOverweight
Apr 2, 2025Lake StreetInitiated—Buy
Mar 20, 2025WedbushReiteratedOutperformOutperform
Mar 20, 2025Stephens & Co.ReiteratedOverweightOverweight